The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

•Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2) in vitro. •A single treatment able to effect ~5000-fold reduction in virus at 48 h in cell culture. •Ivermectin is FDA-approved for parasitic infections, and therefore has a potential for repurposing. •Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines. Although several clinical

[kyukyunyorituryo]

イベルメクチンの核輸送阻害活性がSARS-CoV-2に対して有効である可能性が示唆された。

[powerhouse63w]

ノーベル賞の大村智さんの線虫研究から生まれた薬。イベルメクチン。オーストラリアの研究。

[hihi01]

まじ？